Finance

Lists
Why is AMRUTANJAN up 2,22%?
Dive Deeper
AMRUTANJAN:NSE
Amrutanjan Health Care Ltd
₹512,80
+2,22%
(+11,15) 1D
13 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AMRUTANJAN...
Open
₹505,35
High
₹514,05
Low
₹496,00
Mkt. cap
14,65 mjd
Avg. vol.
44,85 k
Volume
30,02 k
Dividend
0,96%
Quarterly dividend
₹1,23
Ex-dividend date
11 Sep. 2026
P/E ratio
27,46
52-wk high
₹760,15
52-wk low
₹476,50
EPS
₹18,67
Shares outstanding
29,23 m
No. of employees
661
Open
₹505,35
High
₹514,05
Low
₹496,00
Mkt. cap
14,65 mjd
Avg. vol.
44,85 k
Volume
30,02 k
Dividend
0,96%
Quarterly dividend
₹1,23
Ex-dividend date
11 Sep. 2026
P/E ratio
27,46
52-wk high
₹760,15
52-wk low
₹476,50
EPS
₹18,67
Shares outstanding
29,23 m
No. of employees
661
News stories
From web sources and news partners
Profile
Amrutanjan Healthcare Limited is an Indian pharmaceutical company headquartered in Chennai, Tamil Nadu, India. It was founded by Kasinadhuni Nageswara Rao in Bombay in 1893. Wikipedia
About Amrutanjan Health Care Ltd
CEO-
Employees661
Founded1893
HeadquartersChennai, Tamil Nadu, Indië
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,18 mjd
1,41 mjd
1,50 mjd
1,03 mjd
Cost of goods sold
576,55 m
637,94 m
789,58 m
542,79 m
Cost of revenue
576,55 m
637,94 m
789,58 m
542,79 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
297,00 m
374,89 m
-186,16 m
274,66 m
Operating expense
450,77 m
537,01 m
534,06 m
463,91 m
Total operating expenses
1,03 mjd
1,17 mjd
1,32 mjd
1,01 mjd
Operating income
149,68 m
235,44 m
176,08 m
22,98 m
Other non operating income
42,96 m
41,20 m
-126,45 m
38,15 m
EBT including unusual items
192,15 m
263,64 m
210,16 m
60,69 m
EBT excluding unusual items
192,15 m
276,16 m
208,37 m
60,69 m
Income tax expense
52,53 m
69,12 m
48,23 m
17,04 m
Effective tax rate
27,34%
26,22%
22,95%
28,07%
Other operating expenses
138,19 m
145,88 m
704,15 m
170,10 m
Net income
139,62 m
194,52 m
161,93 m
43,66 m
Net profit margin
11,86%
13,79%
10,80%
4,24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
159,20 m
-
Interest expense
-497,00 k
-479,00 k
-459,00 k
-439,00 k
Net interest expenses
-497,00 k
-479,00 k
158,74 m
-439,00 k
Depreciation and amortization charges
15,58 m
16,24 m
16,06 m
19,15 m
EBITDA
165,12 m
248,47 m
189,24 m
38,78 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme